Diabetes

Professional skills: working in multicultural contexts applying participatory and consultative methods; natural coordinator and communicator; dynamic, self-reliant and adaptable; proven ability to quickly develop situational and technical understanding, deliver results in a short time, work independently or as part of a team; negotiation and communication skills dealing with government officials, national and international agencies, local and institutional counterparts, donors and general public.

Nutrition, Public health, HIV/AIDS, reproductive health, gender, WASH, communicable diseases, PHC and community empowerment.

Experienced Chief Executive Officer and Director with a demonstrated history of working in the Medical Device and Healthcare Industry. Skilled in Sales and Marketing, Medical Devices, Management, and Capital Equipment including MRI. Experienced in Diabetes and diabetic complications especially retinopathy, neuropathy and otitis externa.

Diabetes

Mikhail G Kolonin is an Associate Professor and Director of the Center for Metabolic and Degenerative Diseases at the University of Texas in Houston. As a PhD from Wayne State University, he pioneered the concept of expressing peptides disrupting protein interactions in animals. As a Postdoctoral fellow at MD Anderson Cancer Center, he screened combinatorial libraries to identify druggable cell surface markers. Based on this approach, he has invented experimental therapeutics for obesity and cancer. He is an Author of over 60 publications, and has editorial positions with Molecular Carcinogenesis and Cancer Research. He is endowed with a Distinguished University Chair in Metabolic Disease Research.

He has invented experimental therapeutics for obesity and cancer. He is an Author of over 60 publications, and has editorial positions with Molecular Carcinogenesis and Cancer Research. He is endowed with a Distinguished University Chair in Metabolic Disease Research.

Gerald C Hsu received an honourable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines. He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010-2013, then conducted research during 2014-2018. His approach is “math-physics and quantitative medicine” based on mathematics, physics, engineering modelling, signal processing, computer science, big data analytics, statistics, machine learning, and AI. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.

His approach is “math-physics and quantitative medicine” based on mathematics, physics, engineering modelling, signal processing, computer science, big data analytics, statistics, machine learning, and AI.

Serge P. Bottari obtained his MD and his PhD degrees at the Free University Brussels, Belgium. He is specialized in OB/GYN and also obtained a PhD in Biochemistry. He was a Post-Doctoral Fellow and Research Associate at UC San Francisco. After having been a Project Leader at Sandoz and Ciba-Geigy in Basel, Switzerland, he became Professor of Cell Biology at the Medical School and Head of Endocrine Biology at the University Hospital in Grenoble, France, in 1993. He published over 65 articles in premium journals and is a member of several editorial boards. His current work focuses among others on the molecular mechanisms involved in insulin resistance and on the development of novel diagnostic tools.

His current work focuses among others on the molecular mechanisms involved in insulin resistance and on the development of novel diagnostic tools.

Shaaban Abdallah, a professor of Aerospace Engineering, has been at the university of Cincinnati since 1989. He obtained his PhD in Aerospace Engineering at the University of Cincinnati in 1980. Dr. Abdallah joined Penn State University from 1981 to 1988. His research interests include Computational Fluid Dynamics, nano fluids, Turbo-machines, Unmanned Aerial Vehicles and Medical devices. Abdallah has two US patents on centrifugal compressors and three disclosures with university of Cincinnati on medical devices.

Energy loss And coronary flow simulation following hybrid stage l palliation: a hypoplastic left heart computational fluid dynamic model, Interactive cardiovascular and Thoracic Surgery.

David Klachko is a Professor Emeritus in department of Endocrinology, Metabolism and DiabetesIn University of Missouri Health, Columbia

David Klachko research interest in diabetes, metabolism and endocrine disorders.

Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews

Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews